Compare BLCO & CAAP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | CAAP |
|---|---|---|
| Founded | 1853 | 1998 |
| Country | Canada | Luxembourg |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Aerospace |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.5B |
| IPO Year | 2022 | 2017 |
| Metric | BLCO | CAAP |
|---|---|---|
| Price | $17.32 | $23.85 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $18.45 | ★ $26.73 |
| AVG Volume (30 Days) | ★ 389.8K | 194.1K |
| Earning Date | 04-29-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,101,000,000.00 | N/A |
| Revenue This Year | $8.65 | $5.80 |
| Revenue Next Year | $5.59 | $2.36 |
| P/E Ratio | ★ N/A | $26.35 |
| Revenue Growth | ★ 6.47 | N/A |
| 52 Week Low | $13.77 | $17.36 |
| 52 Week High | $18.92 | $30.50 |
| Indicator | BLCO | CAAP |
|---|---|---|
| Relative Strength Index (RSI) | 60.73 | 40.36 |
| Support Level | $16.26 | $21.98 |
| Resistance Level | $17.36 | $26.63 |
| Average True Range (ATR) | 0.43 | 0.90 |
| MACD | 0.03 | -0.17 |
| Stochastic Oscillator | 70.37 | 36.36 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Corporacion America Airports SA acquires, develops, and operates airport concessions. Its operating segments are geographically divided into Argentina, Italy, Brazil, Uruguay, Ecuador, and Armenia. The company generates a majority of its revenue from the Argentina segment. The firm's revenue is categorized into Aeronautical Revenue, Non-Aeronautical Revenue, Commercial Revenue, Construction Service Revenue, and Other Revenue.